Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept Trial.

MLA

See, Aaron Yee Shuen, et al. “Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept Trial.” Kidney & Blood Pressure Research, vol. 49, no. 1, Sept. 2024, pp. 843–51. EBSCOhost, https://doi.org/10.1159/000541568.

APA

See, A. Y. S., Blazeska, E., Shaban, A. A., Thomas, M., Nejad, S. H., Dornelles, A. S., Joyson, A., Burrows, S., Schlaich, M., & Thiruvengadam, S. (2024). Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept Trial. Kidney & Blood Pressure Research, 49(1), 843–851. https://doi.org/10.1159/000541568

Chicago

See, Aaron Yee Shuen, Evgenija Blazeska, Awf Abdulrahman Shaban, Mark Thomas, Sayeh Heidari Nejad, Antonella Soarez Dornelles, Anu Joyson, Sally Burrows, Markus Schlaich, and Srivathsan Thiruvengadam. 2024. “Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept Trial.” Kidney & Blood Pressure Research 49 (1): 843–51. doi:10.1159/000541568.